We are delighted to announce that Bristol-Myers Squibb will be exhibiting as well as recruiting at Jobs Expo Dublin this April.
Bristol-Myers Squibb is one of the world’s biopharma leaders. They deliver innovative medicines for patients fighting serious diseases. They also nurture their own team with inspiring work as well as challenging career options. The company believes that success depends on building teams of bold, innovative and passionate employees who will help to drive them further forward.
Bristol-Myers Squibb in Ireland
Bristol-Myers Squibb manufacturing operations has been located in Ireland since 1964. The company has an active pharmaceutical ingredient manufacturing site based in Swords, Co. Dublin. They also have a distribution centre in Shannon, Co. Clare. In addition, the company has external manufacturing as well as pharmaceutical commercial divisions in Ireland.
In 2014, Bristol-Myers Squibb announced their decision to build a biologics manufacturing facility in Cruiserath, Dublin 15. The $1 billion investment solidifies Bristol-Myers Squibb’s relationship with, as well as their, belief in Ireland.
Established in 1964, the Swords Laboratories was one of the first bulk API manufacturing facilities established in Ireland. It is a flexible and multi-purpose, high-containment manufacturing facility. It comprises several manufacturing plants and functions to support the company’s operations. These includes:
- Quality Control and Assurance
- Manufacturing Science and Technology
- Supply Chain
The site also houses the company’s administration, commercial, medical and treasury teams in Ireland.
The global headquarters for Bristol-Myers Squibb’s external manufacturing organisation is located in Ireland. Employees in Blanchardstown and Shannon manage approximately 100 contract manufacturing sites. As a result, they ensure the company’s active pharmaceutical ingredients and finished medicines meet the highest standards for reliable supply to patients.
This $1 billion biologics manufacturing facility in Dublin 15 specialises in the production of immuno-oncology medicines. This facility is state-of-the-art in its design, as well as technology and processes. When fully operational in late 2018, this biologics plant will employ approximately 440 scientists, engineers, bioprocess operators, and quality specialists as well as other skilled workers.
Bristol-Myers Squibb’s agile environment suits people who are flexible and adaptable to change, as well as those who enjoy teamwork. They endeavour to grow and develop the collective and individual skills of their employees to create a workforce capable of making a true impact.